chr5-83512253-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004385.5(VCAN):c.899C>T(p.Ser300Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0151 in 1,614,130 control chromosomes in the GnomAD database, including 1,350 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004385.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCAN | NM_004385.5 | c.899C>T | p.Ser300Leu | missense_variant | 6/15 | ENST00000265077.8 | NP_004376.2 | |
VCAN | NM_001164097.2 | c.899C>T | p.Ser300Leu | missense_variant | 6/14 | NP_001157569.1 | ||
VCAN | NM_001164098.2 | c.899C>T | p.Ser300Leu | missense_variant | 6/14 | NP_001157570.1 | ||
VCAN | NM_001126336.3 | c.899C>T | p.Ser300Leu | missense_variant | 6/13 | NP_001119808.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCAN | ENST00000265077.8 | c.899C>T | p.Ser300Leu | missense_variant | 6/15 | 1 | NM_004385.5 | ENSP00000265077.3 |
Frequencies
GnomAD3 genomes AF: 0.0150 AC: 2275AN: 152146Hom.: 143 Cov.: 32
GnomAD3 exomes AF: 0.0315 AC: 7927AN: 251294Hom.: 642 AF XY: 0.0346 AC XY: 4704AN XY: 135842
GnomAD4 exome AF: 0.0151 AC: 22099AN: 1461866Hom.: 1209 Cov.: 31 AF XY: 0.0176 AC XY: 12794AN XY: 727234
GnomAD4 genome AF: 0.0149 AC: 2267AN: 152264Hom.: 141 Cov.: 32 AF XY: 0.0168 AC XY: 1249AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 10, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Wagner syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Vitreoretinopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at